Testimonials

Small Molecules

Biological Therapeutics

New Targets

Diagnostics

Enabling Technology

Antibody Catalogue

Register

Privileged Access Section

Anti-HLA-DR Antibody Profile

Antigen: HLA-DR16, 103, 11, 12, 13, 8, 7, 4 (Dw10 only), DR51 (DR15 associated).
Relevance: Human Leukocyte Antigens are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). TAL 16.1 is useful for distinguishing DR1 homozygotes from DR1, DR103 heterozygotes.
Clone: TAL 16.1
Subclass: IgG2a
Applications: ELISA, FACS, Western blot, Immunohistochemistry (Paraffin embedded)
Immunogen: C3H mouse L cells transfected with the HLADRB5*0101 gene
Reactivity: Human
Species raised in: Mouse
Fusion partner: NSO/U
Recommended growth conditions: RPMI 1640 + 10% FCS
References: Sadler A et al. 1993. Tissue Antigens. 41:42-46 PubMed Logo
Munksgaard. 1993. Immunogenetics. 32:51-55
Notes: Cytotoxic with rabbit complement. Western blots to dimer and DR beta chain. 29 kDa MW

For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Please note that CRT supplies to distributors only.  However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information.

[back]